LBSP Favicon

Join BIO KOREA 2025

From 6–9 May 2025, the Netherlands Embassy in Seoul, in collaboration with the Netherlands Enterprise Agency (RVO), is organising a trade mission to South Korea focused on the biotech sector. […]

From 6–9 May 2025, the Netherlands Embassy in Seoul, in collaboration with the Netherlands Enterprise Agency (RVO), is organising a trade mission to South Korea focused on the biotech sector. This is a unique opportunity for Dutch biotech companies to explore the South Korean market, attend the international BIO KOREA exhibition, and connect with Korean companies and stakeholders.

Companies can join a curated programme including access to the BIO KOREA trade fair, matchmaking sessions, company visits, and networking events. Eugene Kim, from the Netherlands Embassy in Seoul, is currently working on a strong programme tailored to Dutch biotech interests.

South Korea offers exciting opportunities for companies involved in innovation, drug development, and medical technologies. With growing demand and a well-established biotech infrastructure, it’s a market worth exploring.

There’s already strong interest from the Dutch business community, but a few spots are still available. Want to join and tap into South Korea’s biotech potential?

Check the full programme and register via the RVO website. 

Related posts

Vuurvliegen tijdens Dutch Bio Science Week

Vuurvliegen tijdens Dutch Bio Science Week

Peter Lindenburg winnaar VUURVLIEGEN tijdens Dutch Bio Science Week Den Haag, 4 juli 2025 – Bijna 130 leerlingen van vier basisscholen uit de Leidse regio hebben onderzoeker...

Dutch Bio Science Week 2025 in full swing

Dutch Bio Science Week 2025 in full swing

Dutch Bio Science Week 2025 has brought an extraordinary buzz to Leiden, transforming the city and the Bio Science Park into a hub of discovery, connection, and inspiration. Over...

Algemene Rekenkamer (Court of Audit) visits LBSP

Algemene Rekenkamer (Court of Audit) visits LBSP

The Court of Audit visited LBSP to explore how science and entrepreneurship create public value, with stops at TNO, Peregrion, NTrans, and VarmX sparking discussion on biotech innovation.